Atrial fibrillation: Difference between revisions
Gerald Chi (talk | contribs) mNo edit summary |
|||
Line 58: | Line 58: | ||
===Surgery=== | ===Surgery=== | ||
[[Atrial fibrillation invasive treatment#Radiofrequency ablation|Radiofrequency Ablation]] | [[Atrial fibrillation surgical treatment|Maze Open Heart Surgery]] | [[Atrial fibrillation invasive treatment#Radiofrequency ablation|Radiofrequency Ablation]] | [[AV nodal ablation]] | [[Atrial fibrillation surgical treatment|Maze Open Heart Surgery]] | ||
===[[Atrial fibrillation secondary prevention|Secondary Prevention]]=== | ===[[Atrial fibrillation secondary prevention|Secondary Prevention]]=== |
Revision as of 13:37, 6 September 2013
![]() |
Resident Survival Guide |
![]() |
Sinus rhythm ![]() |
Atrial fibrillation ![]() |
Atrial Fibrillation Microchapters | |
Special Groups | |
---|---|
Diagnosis | |
Treatment | |
Cardioversion | |
Anticoagulation | |
Surgery | |
Case Studies | |
Atrial fibrillation On the Web | |
For patient information, click here. Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: AF; afib; lone fibrillator
Overview
Classification
Pathophysiology
Causes
Differentiating Atrial Fibrillation from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Special Groups
Postoperative AF | Acute Myocardial Infarction | Wolff-Parkinson-White Preexcitation Syndromes | Hypertrophic Cardiomyopathy | Hyperthyroidism | Pulmonary Diseases | Pregnancy
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | EKG Examples | Afib with LBBB EKG Examples | Chest X Ray | Echocardiography | Holter Monitoring and Exercise Stress Testing | Cardiac MRI
Treatment
Cardioversion
Overview | Electrical Cardioversion | Pharmacological Cardioversion
Anticoagulation
Overview | Warfarin | Converting from or to Warfarin | Converting from or to Parenteral Anticoagulants | Dabigatran
Dabigatran
Dosing | Discontinuation for Surgery and Interventions | Warnings and Precautions | Adverse Reactions | Use in Specific Populations Such as Pregnancy | Overdosage | Clinical Pharmacology | FDA Review of the RE-LY Data | A comparison of the RE-LY and Rocket AF Trials | Estimates of Cost Per Year of Life Saved for Dabigatran
Rate and Rhythm Control
Rate Control | Maintenance of Sinus Rhythm
Surgery
Radiofrequency Ablation | AV nodal ablation | Maze Open Heart Surgery
Secondary Prevention
Supportive Trial Data
Case Studies
Related Chapters
- Atrial flutter
- Ashman phenomenon
- The AF Living Guidelines: Vote on current recommendations and suggest revisions to the guidelines